AUM$15.0M
Expense Ratio0.55%
NAV$20.79
HoldingsN/A
InceptionJan 7, 2025
Price Chart
Key Statistics
Previous Close
N/ADay Range
N/A52-Week Range
$15.51$22.34
Avg Volume
609Dividend Yield
0.32%Expense Ratio
0.55%AUM
$15.0MShares Outstanding
572.0KCountry Allocation
| Country | Weight % |
|---|---|
| United States | 95.87% |
| Ireland | 2.06% |
| Australia | 1.94% |
| Other | 0.13% |
Fund Information
- Issuer
- Alger
- Inception Date
- Jan 7, 2025
- Exchange
- NYSE_ARCA
- Description
- Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in the securities of the underlying index. The underlying index is comprised of U.S. equity securities that the manager believes represent innovative companies that the market has not yet recognized which are developing or benefitting from new products, services, technologies, or advancements.
The Alger Russell Innovation ETF (INVN) is an exchange-traded fund issued by Alger that launched on Jan 7, 2025. It currently manages $15.0M in assets under management. The fund charges an expense ratio of 0.55%.
Top 10 holdings represent 21.7% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | ENPH | Enphase Energy, Inc. | 2.29% | 10242 | $34.4M |
| 2 | FFIV | F5, Inc. | 2.24% | 1251 | $33.6M |
| 3 | ILMN | Illumina, Inc. | 2.19% | 2353 | $32.9M |
| 4 | EXPE | Expedia Group, Inc. | 2.17% | 1147 | $32.6M |
| 5 | ETSY | Etsy, Inc. | 2.15% | 5592 | $32.3M |
| 6 | BMRN | BioMarin Pharmaceutical Inc. | 2.14% | 5543 | $32.1M |
| 7 | PATH | UiPath, Inc. Class A | 2.13% | 20257 | $32.0M |
| 8 | CCCS | CCC Intelligent Solutions Holdings Inc | 2.12% | 39818 | $31.8M |
| 9 | NTNX | Nutanix, Inc. Class A | 2.11% | 6344 | $31.7M |
| 10 | DOX | Amdocs Limited | 2.11% | 3962 | $31.7M |
| 11 | MRK | Merck & Co., Inc. | 2.10% | 2943 | $31.5M |
| 12 | TWLO | Twilio, Inc. Class A | 2.10% | 2350 | $31.5M |
| 13 | REGN | Regeneron Pharmaceuticals, Inc. | 2.09% | 416 | $31.4M |
| 14 | GNTX | Gentex Corporation | 2.09% | 13088 | $31.4M |
| 15 | BMY | Bristol-Myers Squibb Company | 2.08% | 5907 | $31.2M |
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | N/A | — | ||
| 1W | -1.26% | — | ||
| 1M | -4.64% | — | ||
| 3M | -12.58% | — | ||
| 6M | -9.05% | — | ||
| YTD | -10.67% | — | ||
| 1Y | +4.88% | — | ||
| 3Y | -4.57% | — | ||
| 5Y | -4.57% | — |
Moving Averages
20-Day MA
$19.42
Below 20-Day MA50-Day MA
$20.48
Below 50-Day MA200-Day MA
$20.28
Below 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$22.34
Current Price
$19.14
52-Week Low
$15.51
$15.51$22.34
Current Yield
0.32%
Annual Dividend
$0.0620
Frequency
0x/year
Last Ex-Date
Dec 18, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 18, 2025 | $0.0620 | Dec 31, 2025 |
Dividend Payments Over Time
Category Comparison
No category data available for comparison.
Compare with Another ETF
Search for an ETF to compare with INVN: